NASDAQ Companies

BRENTWOOD, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) — Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the […]

Dosing XTX301 at 45 ug/kg once every three weeks (dose level 3) in ongoing Phase 1 trial, nearly 100x the […]

EMERYVILLE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today the Board […]

Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose (RP2D) expected in Q2 […]

Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis (MG) […]

CHARLESTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic […]

BRADENTON, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), […]

Sets Initial Business Outlook for Fiscal Year 2024 Focused on Five Key Strategic Initiatives FORT LAUDERDALE, Fla., Jan. 08, 2024 […]

Preliminary unaudited revenue expected to be between $17.5 million and $18.0 million for Q4 2023 and between $64.9 million and […]

DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today previewed […]